Cohance Lifesciences said that the United States Food and Drug Administration (US FDA), post an inspection, has issued a Form FDA 483 with four observations to the company's formulation (FDF) plant located at Telangana.
Market Samachar is a news aggregator. This article was originally published by Share Market Today. Tap the button above to read the full story on their site.